Financial Reports

29-Oct-2024	September 2024 Quarterly Activities report and Appendix 4C

27-Sep-2024	Appendix 4G and Corporate Governance Statement

29-Aug-2024	Appendix 4E Preliminary Final Report

23-Jul-2024	June 2024 Quarterly Activities Report and Appendix 4C

29-Apr-2024	March 2024 Quarterly Activities Report and Appendix 4C

27-Feb-2024	Appendix 4D and Half Year 2024 Financial Report

22-Jan-2024	December 2023 Quarterly Activities Report and Appendix 4C

13-Oct-2023	September 2023 Activities Report and Appendix 4C

31-Aug-2023	Appendix 4E and Audited Financial Statements

31-Aug-2023	Appendix 4G and Corporate Governance Statement

14-Jul-2023	June 2023 Activities Report and Appendix 4C

24-Apr-2023	March 2023 Quarterly Activities Report and Appendix 4C

24-Feb-2023	Appendix 4D and Half Year 2023 Financial Report

27-Jan-2023	December 2022 Quarterly Activities Report and Appendix 4C

21-Oct-2022	September 2022 Quarterly Activities Report and Appendix 4C

25-Aug-2022	Appendix 4E and Audited Financial Statements

25-Aug-2022	Appendix 4G and Corporate Governance Statement

27-Jul-2022	June 2022 Quarterly Activities Report and Appendix 4C

28-Apr-2022	March 2022 Quarterly Activities Report and Appendix 4C

21-Feb-2022	Appendix 4D and Half Year 2022 Financial Report

27-Jan-2022	December 2021 Quarterly Activities Report and Appendix 4C

14-Oct-2021	September 2021 Quarterly Activities Report and Appendix 4C

10-Sep-2021	Noxopharm 2021 Annual Report

26-Aug-2021	Appendix 4E and Audited Financial Statements

27-Jul-2021	June 2021 Quarterly Activities Report and Appendix 4C

27-Apr-2021	March Quarterly Activities Report and Appendix 4C

16-Feb-2021	Appendix 4D and Half Year Financial Report

25-Jan-2021	Noxopharm Dec 2020 Quarterly Activities Report & Appendix 4C

15-Oct-2020	Noxopharm September 2020 Quarterly Activities Report & Appendix 4C

31-Aug-2020	Appendix 4E and Audited Financial Statements FY2020

29-Jul-2020	Noxopharm 2020 June quarter Appendix 4C & Activities Report

30-Apr-2020	Noxopharm March 2020 Quarterly Report & Appendix 4C

25-Feb-2020	Half Year Accounts and Chairman Letter

31-Jan-2020	Noxopharm December 2019 Quarterly Activities Report & Appendix 4C

30-Oct-2019	Appendix 4C - Quarterly Report for The Quarter Ending September 30, 2019

29-Aug-2019	FY 19 Appendix 4E and Audited Financial Statements

29-Jul-2019	Appendix 4C - Quarterly Report for the quarter ending June 30, 2019

21-Feb-2019	Appendix 4D and Half Year Accounts

29-Jan-2019	Appendix 4C - quarterly report for the quarter ended December 31, 2018

26-Oct-2018	Appendix 4C - Quarterly report for the quarter ended September 30, 2018

30-Aug-2018	Appendix 4E and Audited Financial Statements

30-Jul-2018	Appendix 4C- Quarterly report for the quarter ended June 30, 2018

23-Feb-2018	Appendix 4D and Half Year Accounts

30-Oct-2017	Appendix 4C – Quarterly report for the quarter ended September 30, 2017

31-Aug-2017	Appendix 4E and Audited Financial Statements

31-Jul-2017	Appendix 4C – Quarterly report for the quarter ended June 30, 2017

27-Apr-2017	Appendix 4C – Quarterly report for the quarter ended 31 March 2017

3-Apr-2017	Appendix 3B

24-Feb-2017	Appendix 4D and Half Year Accounts

30-Jan-2017	Appendix 4C – Quarterly report for the quarter ended 31 December 2016

9-Jan-2017	Appendix 3B

20-Dec-2016	Market Capitalisation - further update

20-Dec-2016	Appendix 3B

23-Nov-2016	Results of Meeting

31-Oct-2016	Appendix 4C – Quarterly report for the quarter ended 30 September 2016

21-Oct-2016	Notice of 2016 AGM and 2016 Annual Report

3-Oct-2016	Annual Report 2016

31-Mar-2016	Financial Report

Copyright © Noxopharm